2024 ASCO® Annual Meeting Insights Hub
Meeting coverage & Vumedi’s exclusive highlights, all in one place.
Summaries & Highlights
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 H&N Cancer Highlights: Key Insights From Clinical Trials
FEATURING
Katie Kerrigan
- 328 views
- August 27, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO 2024 Highlights: Insights From Key Abstracts on mBC
FEATURING
Sramila Aithal
- 218 views
- August 27, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
Highlights of Recent Updates in CML: Impact on Practice
FEATURING
Ehab Atallah
- 56 views
- August 27, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Highlights: Advances in GIST Tumors and Soft Tissue Sarcomas
FEATURING
Atif Hussein
- 227 views
- August 12, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
Highlights of Recent Updates in Myeloma: Part 2 - R/R Treatment
FEATURING
Andrzej Jakubowiak
- 267 views
- July 31, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
Highlights of Recent Updates in Myeloma: Part 1 - Frontline Treatment
FEATURING
Andrzej Jakubowiak
- 324 views
- July 31, 2024
- 3
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Prostate Cancer Take-Home Messages
FEATURING
Eleni Efstathiou
- 623 views
- July 29, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Gynecological Cancers Highlights"
FEATURING
Mansoor Raza Mirza
- 1,089 views
- June 18, 2024
- 5
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "CRC Key Studies Including TRANSMET, CheckMate 8HW, NEOPRISM, and PanaMa"
FEATURING
Richard Kim,
Tiago Biachi
- 593 views
- June 20, 2024
- 5
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Breast Cancer Highlights: Top 5 Abstracts - DESTINY-Breast06, postMONARCH, A-BRAVE, Dato/Durva in I-SPY 2.2, and SACI-IO HR+
FEATURING
Paolo Tarantino
- 2,486 views
- June 21, 2024
- 16
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 H&N Highlights: "Key Trial Updates in H&N Cancers"
FEATURING
Nabil Saba
- 1,123 views
- June 13, 2024
- 5
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Current Updates in RCC - Clinical Implications for the Practicing Oncologist"
FEATURING
Kriti Mittal
- 391 views
- July 16, 2024
- 4
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NSCLC), HERKULES-3 Trial (CRC), Novel Agents in ER+/HER2- BC
FEATURING
Vivek Subbiah
- 693 views
- June 14, 2024
- 5
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Breast Cancer Highlights - Monday Morning Practice
FEATURING
Sara Tolaney,
Hope Rugo
- 5,573 views
- June 7, 2024
- 34
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Lymphoma Highlights"
FEATURING
Bruce D. Cheson
- 1,774 views
- June 19, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
Developmental Therapeutics Highlights From ASCO® 2024
FEATURING
Guru Sonpavde
- 558 views
- July 5, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Lung Cancer Highlights: Top Abstracts Including BEAT-SC, ADRIATIC, KRYSTAL-12, and LAURA Trials
FEATURING
Balazs Halmos
- 935 views
- June 21, 2024
- 11
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Lung Cancer Highlights: CROWN, LAURA, ADRIATIC, and PALOMA-3 Trials
FEATURING
Luis Raez
- 735 views
- June 14, 2024
- 5
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Gynecologic Oncology Updates"
FEATURING
Ritu Salani
- 2,323 views
- July 1, 2024
- 15
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Advancing GI Cancer Treatment - The Clinical Utility of ctDNA"
FEATURING
Stacey Cohen
- 362 views
- June 17, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Insights in Melanoma"
FEATURING
Omid Hamid
- 502 views
- June 21, 2024
- 5
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Highlights in Sarcomas
FEATURING
Robin Jones
- 256 views
- July 12, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Bladder and RCC Highlights"
FEATURING
Karine Tawagi,
Natalie Reizine
- 270 views
- July 16, 2024
- 4
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Expert Panel Discussion on CRC Including TRANSMET and ARC-9 Trials"
- 365 views
- June 10, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Expert Panel Discussion on Upper-GI Cancers Including ESOPEC and ARMANI Trials"
- 558 views
- June 10, 2024
- 4
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "My Personal Highlights in Melanoma"
FEATURING
Sapna Patel
- 881 views
- July 11, 2024
- 4
Insights from 2024 EHA Annual Meeting
AML, MDS, and CML Highlights & Key Takeaways From ASCO®/EHA 2024
FEATURING
Talha Badar
- 839 views
- July 16, 2024
- 4
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Fruquintinib in Refractory mCRC"
FEATURING
Cathy Eng
- 217 views
- July 9, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
SCLC Treatment Evolution - Debunking Myths, IO Advances, and Long-Term Strategies
FEATURING
Anne Chiang
- 484 views
- July 10, 2024
- 3
COR2ED The Heart of Medical Education
ASCO® 2024 Summary: "Latest Practice-Changing Data in Breast Cancer, NSCLC, HCC, and Upper-GI Cancers"
- 192 views
- July 9, 2024
- 3
COR2ED The Heart of Medical Education
ASCO® 2024 Summary: "Latest Practice-Changing Data in Gastroesophageal and Colorectal Cancers"
- 223 views
- July 8, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Prostate Cancer Highlights"
FEATURING
Natalie Reizine,
Karine Tawagi
- 584 views
- July 10, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Expert Recap: "Metastatic Breast Cancer Deep Dive & Clinical Implications"
FEATURING
Sara Tolaney,
Hope Rugo
- 940 views
- July 4, 2024
- 5
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Treatment of Relapsed HL - Updated Options in Light of New Frontline Therapies"
FEATURING
Patrick Johnson
- 445 views
- June 7, 2024
- 6
ecancer
ASCO® 2024 Lung Cancer Updates: CROWN, ADRIATIC, and LAURA Trials
FEATURING
Luis Raez
- 69 views
- July 2, 2024
- 1
ecancer
ASCO® 2024: Highlights and Analysis of Key Solid Cancer Trials
FEATURING
Bishal Gyawali
- 105 views
- July 2, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Highlights in Melanoma - Neoadjuvant and Adjuvant Treatments, 1L Metastatic & Anti-PD-1 Refractory Disease"
FEATURING
Zeynep Eroglu
- 341 views
- July 5, 2024
- 3
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "The Best of Myeloma - Review of the Top 5 Abstracts"
FEATURING
Hamza Hashmi
- 662 views
- July 1, 2024
- 5
2024 ASCO® Annual Meeting Insights Hub
Bladder Cancer Highlights From ASCO® 2024
FEATURING
Guru Sonpavde
- 1,902 views
- June 10, 2024
- 13
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Quadruplets in NDMM - The More the Better?"
FEATURING
Ola Landgren
- 423 views
- June 12, 2024
- 7
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Highlights in Early Stage, 1L Metastatic, and Refractory Melanoma"
FEATURING
Douglas Johnson
- 561 views
- June 7, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "News in Head&Neck Cancers"
FEATURING
Paolo Bossi
- 538 views
- June 14, 2024
- 11
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Comparative Review of Toxicities and Their Management With Bispecific Agents in MM and B-Cell NHL"
FEATURING
Monique Minnema
- 288 views
- June 7, 2024
- 4
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Advances in RCC and Urothelial Carcinoma - Key Updates From the CheckMate 9ER, JAVELIN Renal 101, and CheckMate 901 Trials"
FEATURING
Camillo Porta
- 98 views
- June 26, 2024
- 2
Insights from 2024 EHA Annual Meeting
Highlights in Plasma Cell Disorders From ASCO® and EHA
FEATURING
Samer Al Hadidi
- 486 views
- June 27, 2024
- 7
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Experts Discuss Key Updates in Colorectal Cancer"
FEATURING
Sakti Chakrabarti,
Aditya Shreenivas
- 408 views
- June 26, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Timing of Debulking Surgery in Advanced Endometrial and Ovarian Cancers"
FEATURING
Amer Karam
- 465 views
- June 26, 2024
- 6
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Treatment Strategies and QoL Impact in mCRPC - Key Updates From the MANCAN2, EMBARK, PRESTO, and PSMAfore Trials"
FEATURING
Channing Paller
- 175 views
- June 26, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Experts Discuss Key Updates in Gastroesophageal Cancers"
FEATURING
Aditya Shreenivas,
Sakti Chakrabarti
- 139 views
- June 26, 2024
2024 ASCO® Annual Meeting Insights Hub
Experts Discuss Highlights and Key Takeaways in CLL From ASCO® and EHA
FEATURING
Kerry Rogers,
Jennifer Woyach
- 325 views
- June 21, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Updates in Frontline Management of GE Cancers - Beyond PD-1"
FEATURING
Raghav Sundar
- 151 views
- June 25, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Highlights in Biliary Tract Cancer"
FEATURING
Arndt Vogel
- 115 views
- June 25, 2024
- 1
ecancer
ASCO® 2024 Summary: "Expert Panel Discussion on Best Practices in HRRm Testing in Patients With Metastatic Prostate Cancer"
- 183 views
- June 24, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "HCC Highlights From the CheckMate 9DW and CARES-310 Studies"
FEATURING
Arndt Vogel
- 255 views
- June 25, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Upper-GI Key Studies Including ESOPEC and RENAISSANCE"
FEATURING
Richard Kim,
Rutika Mehta
- 183 views
- June 21, 2024
- 4
ecancer
ASCO® 2024 Summary: "IMROZ & BENEFIT Studies in Newly Diagnosed Myeloma"
FEATURING
Xavier Leleu
- 192 views
- June 24, 2024
- 1
ecancer
ASCO® 2024 Summary: "Expert Panel Discussion on the Real World Evidence on PSA Testing in Prostate Cancer"
- 201 views
- June 24, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "BEAT Trials and Neoadjuvant Strategies - Advances in ES-SCLC and Mesothelioma Treatment"
FEATURING
Melina Marmarelis
- 264 views
- June 20, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Curing Stage IV Melanoma - Where Have We Been and Where Are We"
FEATURING
Pippa Corrie
- 315 views
- June 20, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
Treatment and Outcomes in Select Subpopulations With Breast Cancer
FEATURING
Lisa Carey
- 380 views
- June 18, 2024
- 3
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Experts Discuss Key Studies in HCC and BTC"
FEATURING
Richard Kim,
Tiago Biachi
- 413 views
- June 20, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "The Art and Science of Caring for Older Adults With Myeloid Malignancies"
FEATURING
Kah Poh Loh
- 97 views
- June 16, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Current Status of Bispecific Antibody Therapy in R/R MM"
FEATURING
Meera Mohan
- 169 views
- June 16, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Optimal Treatment Strategies for Younger Patients With AML - Intensive vs. Non-Intensive Approaches"
FEATURING
Christine McMahon
- 294 views
- June 20, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
Understanding New Strategies to Prevent and Manage Chronic GVHD
FEATURING
Betty Hamilton
- 115 views
- June 16, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Expert Panel Discussion on Hepatobiliary Cancer Including CheckMate 9DW and ABC-07 Trials"
- 243 views
- June 10, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Immunotherapy & Beyond - Advances in Systemic Therapy for Patients With Melanoma and Brain Metastases"
FEATURING
Hussein Tawbi
- 206 views
- June 12, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Treatment Considerations for Challenging Populations With Hodgkin Lymphoma"
FEATURING
Cathy Burton
- 118 views
- June 10, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Refining Treatment in Advanced Hepatobiliary Cancers"
FEATURING
Laura Goff
- 129 views
- June 12, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Adopting Cutting-Edge Cell Therapies in Melanoma"
FEATURING
Allison Betof Warner
- 197 views
- June 11, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Unveiling the Unique Identity of Clear-Cell Endometrial Cancer - A Comprehensive Comparative Analysis With Ovarian Counterpart and Other Endometrial Subtypes"
FEATURING
Felix Blanc-Durand
- 142 views
- June 11, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "PD-1-Refractory Advanced Melanoma - Getting to the Finish Line"
FEATURING
Meredith Mckean
- 153 views
- June 10, 2024
- 4
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Immunotherapy & Beyond - Advances in Systemic Therapy for Patients With Melanoma and Brain Metastases"
FEATURING
Hussein Tawbi
- 206 views
- June 12, 2024
- 2
Breast
2024 ASCO® Annual Meeting Insights Hub
ASCO 2024 Highlights: Insights From Key Abstracts on mBC
FEATURING
Sramila Aithal
- 218 views
- August 27, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Impact of ctDNA Surveillance on Clinical Care for Patients With Stage I-III BC"
FEATURING
Marla Lipsyc-Sharf
- 317 views
- July 24, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Genomic Alterations in HR+/HER2- Metastatic Breast Cancer - Co-Occurrence and Prevalence Across Treatment"
FEATURING
Manali Bhave
- 470 views
- July 10, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Young-PEARL Study - Palbociclib + Exemestane With GnRH Agonist vs. Capecitabine in Premenopausal Patients With HR+/HER2- mBC"
FEATURING
Yeon Hee Park
- 273 views
- July 10, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Expert Recap: "Metastatic Breast Cancer Deep Dive & Clinical Implications"
FEATURING
Sara Tolaney,
Hope Rugo
- 940 views
- July 4, 2024
- 5
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "EMBER Study - Imlunestrant, an Oral SERD, in Combination With HER2 Directed Therapy +/- Abemaciclib in ER+/HER2+ Advanced BC"
FEATURING
Manali Bhave
- 127 views
- July 2, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
Management of Higher Risk eBC Including BRCAm, HER2- Subtypes
FEATURING
Milana Dolezal
- 409 views
- July 2, 2024
- 5
ecancer
ASCO® 2024 Insights: "Avelumab in Early TNBC With Residual Disease After Neoadjuvant Chemo or at High Risk After Primary Surgery and Adjuvant Chemo"
FEATURING
Pierfranco Conte
- 75 views
- July 2, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "postMONARCH Trial - Abemaciclib + Fulvestrant vs. Fulvestrant Alone for HR+/HER2- Advanced BC Following Progression on a Prior CDK4/6i + ET"
FEATURING
Kevin Kalinsky
- 376 views
- July 2, 2024
- 1
ecancer
ASCO® 2024 Insights: "Clinical Behavior and Prognostic Impact of Genetic Testing in Young BRCA Breast Cancer Patients"
FEATURING
Matteo Lambertini
- 85 views
- July 2, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Breast Cancer Highlights: Top 5 Abstracts - DESTINY-Breast06, postMONARCH, A-BRAVE, Dato/Durva in I-SPY 2.2, and SACI-IO HR+
FEATURING
Paolo Tarantino
- 2,486 views
- June 21, 2024
- 16
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Breast Cancer Highlights - Monday Morning Practice
FEATURING
Sara Tolaney,
Hope Rugo
- 5,573 views
- June 7, 2024
- 34
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Updated Survival Data in DESTINY-Breast03 Trial - T-DXd vs. T-DM1 in Patients With HER2+ mBC"
FEATURING
Erika Hamilton
- 427 views
- June 18, 2024
ecancer
ASCO® 2024 Insights: "I-SPY2.2 Trial - Pathologic Response to Neoadjuvant Datopotamab Deruxtecan in Breast Cancer"
FEATURING
Jane Meisel
- 242 views
- June 20, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future Hold?"
FEATURING
Erika Hamilton
- 1,997 views
- June 18, 2024
- 8
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "H3B-6545 in Women With ER+/HER2- mBC"
FEATURING
Erika Hamilton
- 34 views
- June 18, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Elucidating the Immune Active State of HR+/HER2- MammaPrint High 2 Early BC"
FEATURING
Erin Cobain
- 370 views
- June 18, 2024
- 3
2024 ASCO® Annual Meeting Insights Hub
DESTINY-Breast06 - T-DXd vs. Physician’s Choice of Chemotherapy in HR+/HER2-Low/Ultralow mBC After Endocrine Therapy
FEATURING
Giuseppe Curigliano
- 1,138 views
- June 18, 2024
- 6
2024 ASCO® Annual Meeting Insights Hub
Treatment and Outcomes in Select Subpopulations With Breast Cancer
FEATURING
Lisa Carey
- 380 views
- June 18, 2024
- 3
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "JBCRG-M06/EMERALD Trial - Trastuzumab & Pertuzumab in Combination With Eribulin Mesylate or a Taxane as 1L Chemotherapeutic Treatment for HER2+ Stage 3/4 BC"
FEATURING
Toshinari Yamashita
- 110 views
- June 17, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Ultra-Sensitive ctDNA Mutation Tracking to Identify MRD and Predict Relapse in Patients With Early BC"
FEATURING
Isaac Garcia-Murillas
- 721 views
- June 17, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
Development and Validation of RSClinN+ Tool for HR+/HER2- Node-Positive BC
FEATURING
Lajos Pusztai
- 851 views
- June 17, 2024
- 5
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "NATALEE Trial - Baseline Characteristics and Efficacy Outcomes in N0 HR+/HER2- eBC"
FEATURING
Denise Yardley
- 874 views
- June 7, 2024
- 6
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "ACE-Breast-02 Trial - ARX788 vs. Lapatinib + Capecitabine in HER2+ ABC"
FEATURING
Xi-Chun Hu
- 55 views
- June 12, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "I-SPY2.2 Trial - Rates of pCR After Neoadjuvant Datopotamab Deruxtecan for High-Risk Stage 2/3 BC"
FEATURING
Jane Meisel
- 227 views
- June 13, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "PRIMED Trial - Prevention of SG-Related Neutropenia & Diarrhea in Patients With TNBC or HR+/HER2- Advanced BC"
FEATURING
Antonio Llombart-Cussac
- 391 views
- June 11, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "SACI-IO HR+ Trial - Sacituzumab Govitecan +/- Pembro in Patients With HR+/HER2- mBC"
FEATURING
Ana Garrido-Castro
- 285 views
- June 13, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "OPERA-01 Study - Palazestrant (OP-1250) vs. SoC for ER+/HER2- Advanced/Metastatic BC After ET & CDK4/6i"
FEATURING
Barbara Pistilli
- 45 views
- June 11, 2024
GU
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Landscape Analysis & Oncologic Outcomes in Advanced Urothelial Carcinoma by NECTIN4 RNA Expression"
FEATURING
Tyler Stewart
- 12 views
- September 25, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Prostate Cancer Take-Home Messages
FEATURING
Eleni Efstathiou
- 623 views
- July 29, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Current Updates in RCC - Clinical Implications for the Practicing Oncologist"
FEATURING
Kriti Mittal
- 391 views
- July 16, 2024
- 4
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Bladder and RCC Highlights"
FEATURING
Karine Tawagi,
Natalie Reizine
- 270 views
- July 16, 2024
- 4
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Prostate Cancer Highlights"
FEATURING
Natalie Reizine,
Karine Tawagi
- 584 views
- July 10, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
Developmental Therapeutics Highlights From ASCO® 2024
FEATURING
Guru Sonpavde
- 558 views
- July 5, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
Bladder Cancer Highlights From ASCO® 2024
FEATURING
Guru Sonpavde
- 1,902 views
- June 10, 2024
- 13
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "CHAARTED2 Trial - Cabazitaxel + Abiraterone vs. Abiraterone Alone Post-Docetaxel for mCRPC"
FEATURING
Christos Kyriakopoulos
- 349 views
- June 12, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "A Clinical-Genetic ctDNA-Based Prognostic Model for Predicting OS in Men With mCRPC Treated With Potent AR Inhibition (Alliance)"
FEATURING
Susan Halabi
- 162 views
- June 26, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Systemic Treatments in Favorable and Very Favorable Risk mRCC - Real-World Evidence From the IMDC"
FEATURING
Martin Zarba
- 248 views
- June 7, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "MAST Study - Metformin in Reducing Progression Among Men on Expectant Management for Low-Risk Prostate Cancer"
FEATURING
Neil Fleshner
- 187 views
- June 11, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "TRANSFORMER Trial - Blood-Based Markers of Differential Efficacy of Bipolar Androgen Therapy and Enzalutamide in mCRPC"
FEATURING
Emmanuel Antonarakis
- 169 views
- June 26, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Impact of Exposure on Outcomes With Enfortumab Vedotin in Patients With Locally Advanced or Metastatic Urothelial Cancer"
FEATURING
Daniel Petrylak
- 175 views
- June 6, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Treatment Strategies and QoL Impact in mCRPC - Key Updates From the MANCAN2, EMBARK, PRESTO, and PSMAfore Trials"
FEATURING
Channing Paller
- 175 views
- June 26, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Advances in RCC and Urothelial Carcinoma - Key Updates From the CheckMate 9ER, JAVELIN Renal 101, and CheckMate 901 Trials"
FEATURING
Camillo Porta
- 98 views
- June 26, 2024
- 2
ecancer
ASCO® 2024 Summary: "Expert Panel Discussion on the Real World Evidence on PSA Testing in Prostate Cancer"
- 201 views
- June 24, 2024
ecancer
ASCO® 2024 Summary: "Expert Panel Discussion on Best Practices in HRRm Testing in Patients With Metastatic Prostate Cancer"
- 183 views
- June 24, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "KEYNOTE-426 Trial - Biomarker Analysis of Pembro + Axitinib vs. Sunitinib for aRCC"
FEATURING
Brian Rini
- 105 views
- June 17, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Organ Preserving and Reconstructive Surgery in Penile Cancer"
FEATURING
Arthur Burnett
- 167 views
- June 19, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "CYCLONE 2 Study - Abemaciclib + Abiraterone in mCRPC"
FEATURING
Tilman Todenhöfer
- 59 views
- June 19, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Study EV-103 - Neoadjuvant Enfortumab Vedotin in Cisplatin-Ineligible MIBC Patients"
FEATURING
Nataliya Mar
- 142 views
- June 21, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "MANCAN2 Trial - Self-Help Cognitive Behavioural Therapy for Hot Flashes and Night Sweats in Patients With Prostate Cancer Receiving ADT"
FEATURING
Simon Crabb
- 137 views
- June 17, 2024
ecancer
ASCO® 2024 Insights: "PSMAfore - HRQoL and Pain in Taxane-Naïve mCRPC Patients Treated with Lutetium-177-PSMA-617"
FEATURING
Karim Fizazi
- 81 views
- June 20, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "EMBARK Post Hoc Analysis of Sexual Activity PROs in Patients Who Were Sexually Active or Interested in Sex at Baseline"
FEATURING
Stephen Freedland
- 146 views
- June 5, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Harnessing the Immune System in RCC - Current and Novel IO Approaches"
FEATURING
David Braun
- 203 views
- June 7, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "EMBARK Study - Impact of Treatment Suspension on HRQoL in High-Risk BCR nmHSPC"
FEATURING
Stephen Freedland
- 162 views
- June 13, 2024
- 1
ecancer
ASCO® 2024 Insights: "CHAARTED2 Trial - Cabazitaxel With Abiraterone vs. Abiraterone Alone in mCRPC Post Docetaxel"
FEATURING
Christos Kyriakopoulos
- 45 views
- June 21, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Belzutifan for Advanced Renal Cell Carcinoma"
FEATURING
Eric Jonasch
- 221 views
- June 5, 2024
2024 ASCO® Annual Meeting Insights Hub
Efficacy & Toxicity of 177Lu-PSMA-617 for mCRPC in a Real-World Setting: Results From the U.S. Expanded Access Program and Comparisons With Phase 3 VISION Data
FEATURING
Vishnu Murthy
- 202 views
- June 5, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "KEYNOTE-361 Trial - Quantitative ctDNA Assessment in Patients With Advanced UC Treated With Pembro or Platinum-Based Chemo"
FEATURING
Thomas Powles
- 187 views
- June 7, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "ARV-766, a PROTAC Androgen Receptor Degrader, in mCRPC - Initial Results of a Phase 1/2 Study"
FEATURING
Daniel Petrylak
- 109 views
- June 6, 2024
ecancer
ASCO® 2024 Insights: "SURE-01/02 Study - Perioperative Sacituzumab Govitecan +/- Pembro in MIBC"
FEATURING
Antonio Cigliola
- 47 views
- June 20, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Evaluation of Persistence and Adherence for Oral and Injectable ADT in US Prostate Cancer Patients"
FEATURING
Jason Hafron
- 792 views
- June 13, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "1L Systemic Therapy Following Adjuvant IO in RCC"
FEATURING
Talal El Zarif
- 256 views
- June 11, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Lenvatinib + Pembro vs. Sunitinib in aRCC - Patterns of Progression and Subsequent Therapy in the CLEAR Trial"
FEATURING
Viktor Grünwald
- 125 views
- June 11, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Clinical Utility of Transcriptomic Signatures to Identify Androgen Receptor and Neuroendocrine Signaling in Prostate Cancer"
FEATURING
Yu-Wei Chen
- 142 views
- June 11, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "CORE-001 Study - Final Results of Cretostimogene Grenadenorepvec + Pembro in BCG-Unresponsive, High-Risk NMIBC With Carcinoma In Situ"
FEATURING
Roger Li
- 32 views
- June 13, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "ABBV-706 Study - Targeted ADC for Advanced Solid Tumors"
FEATURING
Benjamin Garmezy
- 57 views
- June 11, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "CA-62 - A New Biomarker for the Detection of Early Stage RCC"
FEATURING
Evgueni Klinski
- 30 views
- June 11, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "AURA Trial Survival Data - Avelumab as Neoadjuvant Therapy in MIUC"
FEATURING
Jeremy Blanc
- 173 views
- June 10, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "HERCULES Trial - Pembro + Platinum-Based Chemo as 1L Treatment for Advanced Penile Cancer"
FEATURING
Fernando Maluf
- 101 views
- June 10, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "KIM-1 Biomarker Analysis in IMmotion010 - Adjuvant Atezo vs. Placebo in RCC Patients at Increased Risk of Recurrence After Resection"
FEATURING
Laurence Albiges
- 68 views
- June 7, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "CheckMate 67T Trial - Safety & PROs of Subcutaneous vs. IV Nivo in Previously Treated Advanced or Metastatic ccRCC"
FEATURING
Maria Bourlon
- 101 views
- June 7, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "LITESPARK-013 Study Subgroup Analysis - Belzutifan in Advanced ccRCC"
FEATURING
Michael Atkins
- 102 views
- June 10, 2024
GI
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Botensilimab + Balstilimab in Microsatellite Stable mCRC - Assessing Efficacy in Non-Liver Metastatic Sites"
FEATURING
Andrea Bullock
- 142 views
- August 1, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Biomarker-Directed Treatment for Pancreatic Adenocarcinoma - Early Results From the PASS-01 Trial"
FEATURING
Jennifer Knox
- 185 views
- July 9, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Fruquintinib in Refractory mCRC"
FEATURING
Cathy Eng
- 217 views
- July 9, 2024
- 2
COR2ED The Heart of Medical Education
ASCO® 2024 Summary: "Latest Practice-Changing Data in Breast Cancer, NSCLC, HCC, and Upper-GI Cancers"
- 192 views
- July 9, 2024
- 3
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "NETTER-2 Study - Efficacy and Safety of 177Lu-DOTA-TATE in Newly Diagnosed Advanced Grade 2/3 Gastroenteropancreatic NETs"
FEATURING
Philip Philip
- 102 views
- July 8, 2024
- 1
COR2ED The Heart of Medical Education
ASCO® 2024 Summary: "Latest Practice-Changing Data in Gastroesophageal and Colorectal Cancers"
- 223 views
- July 8, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "EA2174 Study - Peri-Operative Nivo & Ipi for Locoregional Esophageal & GEJ Adenocarcinoma"
FEATURING
Michael Gibson
- 92 views
- July 5, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Atezo + Bev as 1L Systemic Therapy for aHCC - Outcomes Based on Child Pugh and ALBI Liver Function"
FEATURING
Michael Storandt
- 89 views
- July 1, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Expert Panel Discussion on CRC Including TRANSMET and ARC-9 Trials"
- 365 views
- June 10, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "The GIANT Trial (EA2186) - Gem & nab-Paclitaxel vs. 5-FU, Leucovorin, & Liposomal Irinotecan in Older Pts With Treatment-Naïve Metastatic Pancreatic Cancer"
FEATURING
Efrat Dotan
- 758 views
- June 7, 2024
- 3
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Expert Panel Discussion on Upper-GI Cancers Including ESOPEC and ARMANI Trials"
- 558 views
- June 10, 2024
- 4
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "3Yr Follow-Up of RATIONALE-306 - Tislelizumab + Chemo vs. Placebo + Chemo as 1L Treatment for Advanced/Metastatic Esophageal SCC"
FEATURING
Harry Yoon
- 163 views
- June 6, 2024
- 3
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Experts Discuss Key Updates in Gastroesophageal Cancers"
FEATURING
Aditya Shreenivas,
Sakti Chakrabarti
- 139 views
- June 26, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "212Pb-DOTAMTATE, a Targeted Alpha Therapy for Pts With Unresectable or Metastatic SSTR+ GEP-NETs"
FEATURING
Jonathan Strosberg
- 210 views
- June 6, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Experts Discuss Key Updates in Colorectal Cancer"
FEATURING
Sakti Chakrabarti,
Aditya Shreenivas
- 408 views
- June 26, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Highlights in Biliary Tract Cancer"
FEATURING
Arndt Vogel
- 115 views
- June 25, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "EXPEL-PANC - A Ph2 Study of BXCL701 + Pembro in mPDAC"
FEATURING
Benjamin Weinberg
- 198 views
- June 6, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "HCC Highlights From the CheckMate 9DW and CARES-310 Studies"
FEATURING
Arndt Vogel
- 255 views
- June 25, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Updates in Frontline Management of GE Cancers - Beyond PD-1"
FEATURING
Raghav Sundar
- 151 views
- June 25, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Upper-GI Key Studies Including ESOPEC and RENAISSANCE"
FEATURING
Richard Kim,
Rutika Mehta
- 183 views
- June 21, 2024
- 4
ecancer
ASCO® 2024 Insights: "Comparing Preoperative Chemo to Neoadjuvant CRT in Patients With Esophageal Adenocarcinoma"
FEATURING
Jens Hoeppner
- 67 views
- June 21, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Expert Panel Discussion on Hepatobiliary Cancer Including CheckMate 9DW and ABC-07 Trials"
- 243 views
- June 10, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Experts Discuss Key Studies in HCC and BTC"
FEATURING
Richard Kim,
Tiago Biachi
- 413 views
- June 20, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "CRC Key Studies Including TRANSMET, CheckMate 8HW, NEOPRISM, and PanaMa"
FEATURING
Richard Kim,
Tiago Biachi
- 593 views
- June 20, 2024
- 5
ecancer
ASCO® 2024 Insights: "Summary of the PASS-01 Trial - 1L FOLFIRINOX vs. Gemcitabine/Nab-Paclitaxel in De Novo Metastatic PDAC"
FEATURING
Jennifer Knox
- 202 views
- June 20, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Time Dependency for HPV ctDNA Detection as a Prognostic Biomarker for Anal Cancer"
FEATURING
Van Morris
- 37 views
- June 19, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "GABARNANCE Trial - Gemcitabine + nab-Paclitaxel vs. CRT With S-1 as Neoadjuvant Treatment for Borderline Resectable Pancreatic Cancer"
FEATURING
Masafumi Ikeda
- 41 views
- June 18, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Advancing GI Cancer Treatment - The Clinical Utility of ctDNA"
FEATURING
Stacey Cohen
- 362 views
- June 17, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "PanaMa Trial - FU/FA Maintenance Therapy With or Without Panitumumab in RAS Wild-Type mCRC"
FEATURING
Dominik Modest
- 313 views
- June 10, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "5-Year Results From the Randomized DYNAMIC Trial - ctDNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer"
FEATURING
Jeanne Tie
- 592 views
- June 5, 2024
- 6
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Efficacy, Safety, and PD of CM24 With Nivo & Chemo in Advanced/Metastatic Pancreatic Cancer"
FEATURING
Teresa Macarulla
- 149 views
- June 5, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Atezolizumab & Varlilumab (CDX-1127) +/- Cobimetinib in Previously Treated Unresectable Biliary Tract Cancer"
FEATURING
Thatcher Heumann
- 45 views
- June 12, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "NEOPRISM-CRC Trial - Neoadjuvant Pembro Stratified to TMB for High-Risk Stage 2 or 3 dMMR/MSI-High CRC"
FEATURING
Kai-Keen Shiu
- 96 views
- June 12, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Refining Treatment in Advanced Hepatobiliary Cancers"
FEATURING
Laura Goff
- 129 views
- June 12, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "FIH Trial of M9140, an Anti-CEACAM5 ADC With Exatecan Payload, in Pts With mCRC"
FEATURING
Scott Kopetz
- 110 views
- June 12, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "NETTER-2 Study - Safety & TTR of [177Lu]Lu-DOTATATE in Pts With Newly Diagnosed Advanced Grade 2 & 3, Well-Differentiated Gastroenteropancreatic NETs"
FEATURING
Pamela Kunz
- 46 views
- June 12, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Randomized ARC-9 Study to Evaluate Etrumadenant-Based Combinations in Previously-Treated mCRC"
FEATURING
Zev A. Wainberg
- 74 views
- June 10, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "ARMANI Trial - Ramucirumab + Paclitaxel as Switch Maintenance vs. Continuation of Oxaliplatin-Based Chemo in Patients With Advanced HER2- GC/GEJC"
FEATURING
Filippo Pietrantonio
- 104 views
- June 10, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "CheckMate 8HW Trial - Nivo + Ipi With Chemo in 1L MSI-H/dMMR mCRC"
FEATURING
Heinz-Josef Lenz
- 75 views
- June 10, 2024
- 1
Lung
2024 ASCO® Annual Meeting Insights Hub
SCLC Treatment Evolution - Debunking Myths, IO Advances, and Long-Term Strategies
FEATURING
Anne Chiang
- 484 views
- July 10, 2024
- 3
ecancer
ASCO® 2024: Highlights and Analysis of Key Solid Cancer Trials
FEATURING
Bishal Gyawali
- 105 views
- July 2, 2024
- 1
ecancer
ASCO® 2024 Insights: "NRG-LU002 Trial - Maintenance vs. Local Consolidative Therapy in Limited mNSCLC"
FEATURING
Puneeth Iyengar
- 39 views
- July 2, 2024
ecancer
ASCO® 2024 Lung Cancer Updates: CROWN, ADRIATIC, and LAURA Trials
FEATURING
Luis Raez
- 69 views
- July 2, 2024
- 1
ecancer
ASCO® 2024 Insights: "HARMONi-A Study - Ivonescimab + Chemo for EGFRm NSCLC Patients Who Progressed on EGFR-TKI Treatment"
FEATURING
Li Zhang
- 33 views
- July 2, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Lung Cancer Highlights: CROWN, LAURA, ADRIATIC, and PALOMA-3 Trials
FEATURING
Luis Raez
- 735 views
- June 14, 2024
- 5
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Lung Cancer Highlights: Top Abstracts Including BEAT-SC, ADRIATIC, KRYSTAL-12, and LAURA Trials
FEATURING
Balazs Halmos
- 935 views
- June 21, 2024
- 11
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "KRYSTAL-12 Study - Adagrasib vs. Docetaxel in Patients With Previously Treated Advanced/Metastatic NSCLC Harboring KRASG12C Mutations"
FEATURING
Tony Mok
- 458 views
- June 13, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "RAGNAR Trial - Erdafitinib Efficacy & Safety in Advanced NSCLC With FGFR Alterations"
FEATURING
Martin Schuler
- 135 views
- June 6, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "SAVE Study - Comparing Suspension vs. Continuation of PD-1 Pathway Blockade in Advanced NSCLC"
FEATURING
Yasushi Goto
- 232 views
- June 13, 2024
- 3
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "BEAT Trials and Neoadjuvant Strategies - Advances in ES-SCLC and Mesothelioma Treatment"
FEATURING
Melina Marmarelis
- 264 views
- June 20, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NSCLC), HERKULES-3 Trial (CRC), Novel Agents in ER+/HER2- BC
FEATURING
Vivek Subbiah
- 693 views
- June 14, 2024
- 5
ecancer
ASCO® 2024 Insights: "ADRIATIC Study - Durvalumab as Consolidation Treatment After Concurrent Platinum-Based CRT for LS-SCLC"
FEATURING
David Spigel
- 87 views
- June 21, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "TROPION-Lung05 Study - Intracranial Efficacy of Dato-DXd in Patients With Previously Treated Advanced/Metastatic NSCLC With Actionable Genomic Alterations"
FEATURING
Aaron Lisberg
- 200 views
- June 21, 2024
- 2
ecancer
ASCO® 2024 Insights: "LAURA Study - Osimertinib After Definitive CRT in Patients With Unresectable Stage 3 EGFRm NSCLC"
FEATURING
Suresh Ramalingam
- 64 views
- June 21, 2024
ecancer
ASCO® 2024 Insights: "Telehealth Palliative Care for Advanced Lung Cancer - Effective Alternative to In-Person Visits"
FEATURING
Joseph Greer
- 30 views
- June 20, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "HARMONi-A Trial - Ivonescimab Combined With Chemo in Patients With EGFRm non-Squamous NSCLC Who Progressed on EGFR-TKI Treatment"
FEATURING
Li Zhang
- 131 views
- June 17, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "ETOP 13-18 BEAT-meso Trial - Bevacizumab + Chemo +/- Atezolizumab as 1L Treatment for Advanced Pleural Mesothelioma"
FEATURING
Sanjay Popat
- 100 views
- June 17, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "LIBRETTO-432 Trial - Adjuvant Selpercatinib vs. Placebo in Stage IB-IIIA RET+ NSCLC"
FEATURING
Jonathan Goldman
- 164 views
- June 14, 2024
- 1
ecancer
ASCO® 2024 Insights: "KRYSTAL-12 Study - Adagrasib vs. Docetaxel in Patients With Previously Treated Advanced/Metastatic NSCLC Harboring a KRASG12C Mutation"
FEATURING
Robert Jotte
- 194 views
- June 21, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "CHRYSALIS-2 Trial - Amivantamab + Lazertinib in Atypical EGFRm Advanced NSCLC"
FEATURING
Byoung Chul Cho
- 68 views
- June 14, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Assessing Secular Trends in Lung Cancer Stage in The United States Community Oncology Setting From 2013 to 2023"
FEATURING
Jessica Paulus
- 106 views
- June 12, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "NRG-LU002 Trial - Maintenance Systemic Therapy +/- Local Consolidative Therapy in Limited mNSCLC"
FEATURING
Puneeth Iyengar
- 89 views
- June 13, 2024
2024 ASCO® Annual Meeting Insights Hub
Impact on Biomarker Documentation in Community Oncology by Optimizing Clinical Decision Support for adjNSCLC, mNSCLC, and mCRPC
FEATURING
Daniel Rubin
- 316 views
- June 13, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Evolution Trial - RT-Free Pembro + Chemo in High PD-L1 LA-NSCLC"
FEATURING
Akito Hata
- 129 views
- June 10, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "MIST5 Trial - Niraparib & Dostarlimab in Platinum-Sensitive Relapsed Mesothelioma"
FEATURING
Dean Fennell
- 111 views
- June 6, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Multi-Center Phase II Trial Investigating Safety & Efficacy of Osimertinib + Consolidative SABR in Advanced EGFRm NSCLC"
FEATURING
Sawsan Rashdan
- 52 views
- June 10, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "PALOMA-2 Study - Subcutaneous Amivantamab & Lazertinib as 1L Treatment in Patients With EGFRm Advanced NSCLC"
FEATURING
Sun Min Lim
- 130 views
- June 11, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "First-in-Human Trial of RSO-021 in Malignant Pleural Effusion Caused by Mesothelioma and Advanced Tumors"
FEATURING
Dean Fennell
- 29 views
- June 6, 2024
Hematologic Oncology
ecancer
Post-Transplant Cyclophosphamide Based GVHD Prophylaxis in Patients Undergoing MMUD HCT
FEATURING
Monzr Al Malki,
Steven Devine
- 48 views
- July 24, 2024
ecancer
ASCO® 2024 Insights: "Importance of MRD in Newly Diagnosed Multiple Myeloma"
FEATURING
Xavier Leleu
- 83 views
- July 18, 2024
- 1
Insights from 2024 EHA Annual Meeting
AML, MDS, and CML Highlights & Key Takeaways From ASCO®/EHA 2024
FEATURING
Talha Badar
- 839 views
- July 16, 2024
- 4
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Benefit of R Maintenance After 1L BR in MCL"
FEATURING
Yucai Wang
- 70 views
- July 11, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "CAPTIVATE Study - 5.5-Year Follow-Up Outcomes of Fixed-Duration Ibrutinib + Venetoclax in High-risk CLL/SLL"
FEATURING
Ryan Jacobs
- 206 views
- July 8, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Liso-Cel in R/R MCL With Prior BTKi Therapy - Results From TRANSCEND NHL 001"
FEATURING
Leo Gordon
- 74 views
- June 30, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Lymphoma Highlights"
FEATURING
Bruce D. Cheson
- 1,774 views
- June 19, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Treatment of Relapsed HL - Updated Options in Light of New Frontline Therapies"
FEATURING
Patrick Johnson
- 445 views
- June 7, 2024
- 6
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Quadruplets in NDMM - The More the Better?"
FEATURING
Ola Landgren
- 423 views
- June 12, 2024
- 7
2024 ASCO® Annual Meeting Insights Hub
Experts Discuss Highlights and Key Takeaways in CLL From ASCO® and EHA
FEATURING
Kerry Rogers,
Jennifer Woyach
- 325 views
- June 21, 2024
- 1
Insights from 2024 EHA Annual Meeting
Highlights in Plasma Cell Disorders From ASCO® and EHA
FEATURING
Samer Al Hadidi
- 486 views
- June 27, 2024
- 7
ecancer
ASCO® 2024 Summary: "IMROZ & BENEFIT Studies in Newly Diagnosed Myeloma"
FEATURING
Xavier Leleu
- 192 views
- June 24, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Post-Transplant Cyclophosphamide-Based GvHD Prophylaxis Following Mismatched Unrelated Donor PBSC Transplantation"
FEATURING
Monzr Al Malki
- 283 views
- June 7, 2024
- 3
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Comparative Review of Toxicities and Their Management With Bispecific Agents in MM and B-Cell NHL"
FEATURING
Monique Minnema
- 288 views
- June 7, 2024
- 4
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Glofitamab Monotherapy in Patients With Heavily Pretreated R/R MCL"
FEATURING
Tycel Phillips
- 70 views
- June 25, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "DREAMM-7 Trial - BelamafVd vs. DaraVd in R/R MM"
FEATURING
Maria-Victoria Mateos
- 295 views
- June 6, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Sequencing Immunotherapy for Myeloma"
FEATURING
Samir Parekh
- 249 views
- June 25, 2024
- 4
ecancer
ASCO® 2024 Insights: "MajesTEC-7 Study - Safety and Efficacy of Tec-DR in NDMM"
FEATURING
Salomon Manier
- 67 views
- June 26, 2024
ecancer
ASCO® 2024 Insights: "Results of Preliminary Safety & Efficacy of Belantamab Mafodotin and Elotuzumab in R/R MM"
FEATURING
Natalia Neparidze
- 74 views
- June 25, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "TRANSFORM Study - 3-Year Follow-Up Comparing Liso-Cel vs. SoC With Salvage Chemo and ASCT as 2L Treatment in R/R LBCL"
FEATURING
Manali Kamdar
- 90 views
- June 20, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "A Prospective Trial of Combining FDG-PET + Whole-Body MRI for Staging Newly Diagnosed and R/R Myeloma"
FEATURING
Claudio Cerchione
- 219 views
- June 7, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Optimal Treatment Strategies for Younger Patients With AML - Intensive vs. Non-Intensive Approaches"
FEATURING
Christine McMahon
- 294 views
- June 20, 2024
- 1
ecancer
ASCO® 2024 Insights: "Long-Term Follow-Up of MajesTEC-1 Trial - Teclistamab in R/R MM"
FEATURING
Alfred Garfall
- 32 views
- June 20, 2024
ecancer
ASCO® 2024 Insights: "CARTITUDE-4 Study - Benefits of Ciltacabtagene Autoleucel in Lenalidomide-Refractory Functional High-Risk MM"
FEATURING
Luciano Costa
- 136 views
- June 24, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Real World Outcomes of Pts With MM Who Received Bispecific Antibodies After CAR-T"
FEATURING
Radhika Bansal
- 133 views
- June 19, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Indirect Comparison of Linvoseltamab Vs. Teclistamab for Triple-Class Exposed R/R MM"
FEATURING
Sundar Jagannath
- 187 views
- June 17, 2024
- 2
ecancer
ASCO® 2024 Insights: "PERSEUS Trial - MRD Analysis of Dara + VRd in Transplant-Eligible NDMM"
FEATURING
Paula Rodríguez-Otero
- 65 views
- June 24, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Current Status of Bispecific Antibody Therapy in R/R MM"
FEATURING
Meera Mohan
- 169 views
- June 16, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
Understanding New Strategies to Prevent and Manage Chronic GVHD
FEATURING
Betty Hamilton
- 115 views
- June 16, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "MRD2STOP Study - Discontinuation of Maintenance Therapy in MM Guided by Multimodal MRD Negativity"
FEATURING
Ben Derman
- 407 views
- June 11, 2024
- 3
ecancer
ASCO® 2024 Insights: "IMROZ - A Ph3 Study of Isatuximab + VRd vs. VRd for Transplant-Ineligible NDMM"
FEATURING
Thierry Facon
- 113 views
- June 24, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "The Art and Science of Caring for Older Adults With Myeloid Malignancies"
FEATURING
Kah Poh Loh
- 97 views
- June 16, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Treatment Considerations for Challenging Populations With Hodgkin Lymphoma"
FEATURING
Cathy Burton
- 118 views
- June 10, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "New Agents on the Horizon in NHL and Myeloma - Targets Other Than CD3/CD20, New Constructs, and Trispecifics"
FEATURING
Paolo Strati
- 48 views
- June 12, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "The BENEFIT Study - Isa-VRd vs. Isa-Rd for Transplant-Ineligible NDMM"
FEATURING
Xavier Leleu
- 158 views
- June 11, 2024
Skin
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Biomarker Analysis & Updated Clinical Outcomes - Neoadjuvant Systemic Treatment With Nivolumab and Relatlimab in Surgically Resectable Melanoma"
FEATURING
Liz Burton
- 135 views
- July 22, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "My Personal Highlights in Melanoma"
FEATURING
Sapna Patel
- 881 views
- July 11, 2024
- 4
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Highlights in Melanoma - Neoadjuvant and Adjuvant Treatments, 1L Metastatic & Anti-PD-1 Refractory Disease"
FEATURING
Zeynep Eroglu
- 341 views
- July 5, 2024
- 3
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Highlights in Early Stage, 1L Metastatic, and Refractory Melanoma"
FEATURING
Douglas Johnson
- 561 views
- June 7, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Insights in Melanoma"
FEATURING
Omid Hamid
- 502 views
- June 21, 2024
- 5
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Safety & Efficacy of First-in-Class CXCR1/2 Inhibitor SX-682 in Combination With Pembro in Patients With Metastatic Melanoma With Disease Progression on Anti-PD-1 Therapy"
FEATURING
Sapna Patel
- 66 views
- June 19, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Curing Stage IV Melanoma - Where Have We Been and Where Are We"
FEATURING
Pippa Corrie
- 315 views
- June 20, 2024
- 1
ecancer
ASCO® 2024 Insights: "NADINA Trial - Neoadjuvant Nivo + Ipi vs. Adjuvant Nivo in Stage III Melanoma"
FEATURING
Christian Blank
- 52 views
- June 20, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Adopting Cutting-Edge Cell Therapies in Melanoma"
FEATURING
Allison Betof Warner
- 197 views
- June 11, 2024
ecancer
ASCO® 2024 Insights: "PIVOTAL Study - Neoadjuvant Daromun vs. Immediate Surgery in Fully Resectable Melanoma"
FEATURING
Axel Hauschild
- 43 views
- June 20, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "QoL Data With Neoadjuvant Ipi & Nivo in Resectable Stage III Melanoma - 36-Week Data From the NADINA Trial"
FEATURING
Judith Lijnsvelt
- 67 views
- June 14, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "PIVOTAL Study - Daromun vs. Immediate Surgery in Resectable Melanoma With Regional Metastases"
FEATURING
Axel Hauschild
- 69 views
- June 11, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "RELATIVITY-047 Trial 3-Year OS and MSS Outcomes - Nivo + Rela vs. Nivo for Previously Untreated Metastatic/Unresectable Melanoma"
FEATURING
Hussein Tawbi
- 496 views
- June 12, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "NADINA Trial - Neoadjuvant Nivo + Ipi in Macroscopic, Resectable Stage 3 Melanoma"
FEATURING
Christian Blank
- 295 views
- June 14, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "SCOPE Trial - Efficacy & Safety of SCIB1 Vaccine With Nivo & Ipi in Advanced Unresectable Melanoma"
FEATURING
Heather Shaw
- 25 views
- June 13, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Macroscopic Stage III Melanoma and Immunotherapy - Pre-op, Post-op or No-op? NADINA Trial Discussion"
FEATURING
Harriet Kluger
- 134 views
- June 10, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Immunotherapy & Beyond - Advances in Systemic Therapy for Patients With Melanoma and Brain Metastases"
FEATURING
Hussein Tawbi
- 206 views
- June 12, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "PD-1-Refractory Advanced Melanoma - Getting to the Finish Line"
FEATURING
Meredith Mckean
- 153 views
- June 10, 2024
- 4
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "NEO-TIM Trial - Combination or Sequence of Vemurafenib, Cobimetinib, and Atezolizumab in High-Risk Resectable Melanoma"
FEATURING
Paolo A. Ascierto
- 41 views
- June 12, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Roginolisib, an Oral, Highly Selective and Allosteric Modulator of PI3Kd for Uveal Melanoma and Advanced Cancers"
FEATURING
Anna Maria Di Giacomo
- 45 views
- June 12, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "KEYNOTE-942 Trial - 3-Year Update on mRNA-4157 & Pembro in Resected Melanoma"
FEATURING
Jeffrey Weber
- 240 views
- June 12, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "RELATIVITY-048 Trial - Efficacy and Safety of Triplet Nivo + Rela + Ipi in Advanced Melanoma"
FEATURING
Paolo A. Ascierto
- 208 views
- June 12, 2024
- 3
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "RegoMel Trial - Regorafenib in Patients With Pretreated Advanced Melanoma"
FEATURING
Iris Dirven
- 33 views
- June 7, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "OBX-115, IL2-Sparing Engineered TIL Cell Therapy for Immune Checkpoint Inhibitor-Resistant Unresectable/Metastatic Melanoma"
FEATURING
Rodabe Amaria
- 40 views
- June 11, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "COMBI-AD Study - Dabrafenib + Trametinib in Stage III BRAF-Mutated Melanoma"
FEATURING
Axel Hauschild
- 534 views
- June 11, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Individualized Neoantigen Therapy mRNA-4157 (V940) + Pembro in Resected Melanoma"
FEATURING
Meredith Mckean
- 36 views
- June 11, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Novel RNA-Nanoparticle Vaccine for the Treatment of Early Melanoma Recurrence Following Adjuvant Anti-PD-1 Antibody Therapy"
FEATURING
Bently Doonan
- 48 views
- June 6, 2024
GYN
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "CARACO Trial - Omission of Lymphadenectomy in Advanced Epithelial Ovarian Cancer Treated With Primary or Interval Cytoreductive Surgery After Neoadjuvant Chemo"
FEATURING
Jean-Marc Classe
- 149 views
- July 10, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Gynecologic Oncology Updates"
FEATURING
Ritu Salani
- 2,323 views
- July 1, 2024
- 15
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Timing of Debulking Surgery in Advanced Endometrial and Ovarian Cancers"
FEATURING
Amer Karam
- 465 views
- June 26, 2024
- 6
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Unveiling the Unique Identity of Clear-Cell Endometrial Cancer - A Comprehensive Comparative Analysis With Ovarian Counterpart and Other Endometrial Subtypes"
FEATURING
Felix Blanc-Durand
- 142 views
- June 11, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Gynecological Cancers Highlights"
FEATURING
Mansoor Raza Mirza
- 1,089 views
- June 18, 2024
- 5
ecancer
ASCO® 2024 Insights: "CARACO Trial - Omission of Lymphadenectomy in Advanced Epithelial Ovarian Cancer"
FEATURING
Jean-Marc Classe
- 139 views
- June 21, 2024
- 1
ecancer
ASCO® 2024 Insights: "BrUOG 354 Trial - Nivo Alone or in Combination With Ipi for People With Ovarian and Other Extra-Renal CCCs Who Had Relapsed After Prior Therapy"
FEATURING
Don Dizon
- 109 views
- June 21, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "BrUOG 354 Trial Final Results - Nivo vs. Nivo/Ipi for Ovarian & Other Extra-Renal Clear Cell Carcinomas"
FEATURING
Don Dizon
- 204 views
- June 13, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "ALARICE Study - Avelumab With Axitinib in Persistent/Recurrent Cervical Cancer After Platinum-Based Chemo"
FEATURING
Ka Yu Tse
- 60 views
- June 6, 2024
Head & Neck
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 H&N Cancer Highlights: Key Insights From Clinical Trials
FEATURING
Katie Kerrigan
- 328 views
- August 27, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "FIREFLY-1 Trial - Type II RAF Inhibitor Tovorafenib in R/R Pediatric Low Grade Glioma"
FEATURING
David Ziegler
- 178 views
- July 11, 2024
- 3
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Analyses of TTX-080, a First-in-Class HLA-G Antagonist, in Combination With Cetuximab in Patients With mCRC and HNSCC"
FEATURING
Susanna Ulahannan
- 53 views
- July 3, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Petosemtamab With Pembro as 1L Treatment of Recurrent/Metastatic HNSCC"
FEATURING
Cesar Perez
- 92 views
- July 3, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 H&N Highlights: "Key Trial Updates in H&N Cancers"
FEATURING
Nabil Saba
- 1,123 views
- June 13, 2024
- 5
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "News in Head&Neck Cancers"
FEATURING
Paolo Bossi
- 538 views
- June 14, 2024
- 11
ecancer
ASCO® 2024 Insights: "E3311 Trial - Enhancing Oropharynx Cancer Outcomes With Transoral Surgery and Deintensified Post-Op Care"
FEATURING
Barbara Burtness
- 44 views
- June 20, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Triple Oral Metronomic Therapy + Chemo Regimen vs. Chemo Alone in Advanced Unresectable HNSCC"
FEATURING
Akhil Kapoor
- 83 views
- June 12, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "PRGN-2012, a Novel Gorilla Adenovirus-Based IO, Provides the First Treatment That Leads to Complete & Durable Responses in Recurrent Respiratory Papillomatosis Patients"
FEATURING
Scott Norberg
- 84 views
- June 7, 2024
- 1
Sarcoma
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Highlights: Advances in GIST Tumors and Soft Tissue Sarcomas
FEATURING
Atif Hussein
- 227 views
- August 12, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Efficacy of Nirogacestat in Patients With Poor Prognostic Factors for Desmoid Tumors - Analyses From the DeFi Study"
FEATURING
Bruno Vincenzi
- 48 views
- July 25, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Highlights in Sarcomas
FEATURING
Robin Jones
- 256 views
- July 12, 2024
- 2
ecancer
ASCO® 2024 Insights: "Monitoring Ovarian Function in DeFi Study - Nirogacestat in Desmoid Tumors"
FEATURING
Elizabeth Loggers
- 38 views
- June 24, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Sorafenib Treatment Duration in Desmoid Tumors"
FEATURING
Philippos Costa
- 68 views
- June 17, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "PROs of the MEDISARC Study (AIO-STS-0415) - Durvalumab & Tremelimumab vs. Doxorubicin in Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma"
FEATURING
Viktor Grünwald
- 80 views
- June 12, 2024
- 1